Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
"Prime Broker of the Year": Ripple Prime Wins Major US Award

"Prime Broker of the Year": Ripple Prime Wins Major US Award

UTodayUToday2026/10/11 10:24

Ripple's institutional prime brokerage firm dubbed Ripple Prime has secured a major win at the recent 2026 Hedgeweek US Awards.

Ripple Prime emerges as prime broker of the year

According to a recent report, Ripple Prime has won the Prime Broker of the Year: EMEA award at the 2026 Hedgeweek US Awards.

While the organizers of the event are renowned for their high reputation in the finance space, the award has earned Ripple Prime major recognition for its brokerage services to institutional clients.

Furthermore, the award proves Ripple Prime's efficiency in serving institutional investors as demand for digital asset services continues to increase.

With this top brokerage honor, Ripple Prime has earned a spot among a group of financial service providers acknowledged for their contributions to the hedge fund and digital asset industries.

About the 2026 Hedgeweek US Awards

The Hedgeweek US Awards is an annual event that honors and recognizes companies for their efficiency and contributions across several categories.

Some of these categories include custody, trading infrastructure, blockchain technology, compliance, and decentralized finance (DeFi).

Apart from Ripple, another notable winner from the crypto industry was BitGo, which took home the Prime Broker of the Year award for the US and Custodian of the Year in both the US and global categories. 

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.

The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.

智通财经•2026/10/16 00:11